Strata Critical Medical, Inc.
4.66USD
-0.0500 (-1.06%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SRTA.
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 73 | 67 | 67 | 49 | 45 | 36 | 36 | 36 |
| Cost of Revenue | 57 | 53 | 55 | 38 | 36 | 29 | 31 | 29 |
| Gross Profit | 15 | 14 | 12 | 12 | 9 | 7 | 5 | 8 |
| Operating Income | -5 | -3 | -6 | -6 | -5 | -6 | -6 | -7 |
| Net Income | -11 | 2 | -9 | 57 | -4 | -3 | -10 | -2 |
| EPS (Diluted) | -$0.12 | $0.03 | -$0.12 | $0.70 | -$0.05 | -$0.04 | -$0.12 | -$0.03 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)